May 23, 2008
BULLETIN
NIAID AIDS Vaccine Research Subcommittee to Meet
May 30 to Discuss PAVE 100 Study
Watch Live Via Webcast
| WHAT: |
|
On Friday, May 30, 2008, the AIDS Vaccine Research Subcommittee (AVRS), a component of the National Institute of Allergy and Infectious Diseases (NIAID) AIDS Research Advisory Committee, will meet in Bethesda, Md., to discuss the proposed HIV vaccine study known as PAVE 100.
During the meeting, the study’s proposed protocol design will be presented along with a discussion of the community consultations that have been conducted thus far concerning the trial. The status of the PAVE 100 study will not be decided at the close of the AVRS meeting. Rather, at this meeting, the AVRS is expected to provide to NIAID a technical assessment of the proposed study and its investigational vaccine. Using this assessment and other pertinent input, a decision as to whether to move forward with PAVE 100 will be made by NIAID Director Anthony S. Fauci, M.D. |
| WHERE: |
|
The meeting will be held at the Bethesda North Marriott and Conference Center, 5701 Marinelli Road, North Bethesda, Md. 20852. Onsite registration will be available.
The AVRS meeting will be Webcast live on May 30. |
| WHEN: |
|
Friday, May 30, 2008
8:00 a.m. to 4:00 p.m. EST |
| CONTACT: |
|
For more information, contact the NIAID Office of Communications at (301) 402-1663, niaidnews@niaid.nih.gov. |
Media inquiries can be directed to the NIAID Office of Communications at 301-402-1663, niaidnews@niaid.nih.gov.
NIAID is a component of the National Institutes of Health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on basic immunology, transplantation and immune-related disorders, including autoimmune diseases, asthma and allergies.
The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov
###
back to top